spacer
home > directory > Ecron Acunova
PHARMACEUTICAL INDUSTRY DIRECTORY

Ecron Acunova

Ecron Acunova

Ecron Acunova, a full-service expert CRO with over two decades of sound experience in various therapeutic areas, provides end-to-end services for Phase I - IV clinical research including clinical trial management, clinical data management, PK/PD services and central lab.

Ecron Acunova covers 15 western and eastern European countries including Russia & Ukraine, plus India. As regional experts, we operate each region as a priority market with a European HQ at Frankfurt, Germany, and an Asian HQ at Bangalore, India. Supplemented by our membership in the inVentiv Clinical Global Alliance we offer a well-directed multi-continental geographical spread.

We provide an attractive package of services coupled with the ability to rapidly conduct clinical trials by utilising a world class delivery platform. Our considerable track record, wide geographic presence, extensive patient access, regulatory credibility, quality standards as well as cultural diversity and excellent capabilities of our team, serve our clients’ benefits.

Ecron Acunova offers clinical development services to pharmaceutical, biotechnology, nutritional, device and medical diagnostics industry.

Ecron Acunova creates value to its clients:

  • By handling each of the projects with first priority and personalised services tailored to the client’s needs
  • Through its deep regional competence, by optimising research strategies with an intelligent combination of complementing advantages in developed and emerging countries

Highlights:

  • Our direct presence within key emerging trial locations such as India and eastern Europe provides access to large diverse patient pools that match the demographies of relevant indications of large markets and facilitate outstanding recruitment. In India, for example, we have preferred access to 19 teaching hospitals of Manipal University - Asia's largest academic medical centre where more than 1,500 physicians treat 1,5 million patients every year. Excellent patient access and speedy recruitment lead to beneficial time and budget effects for our clients.
  • We have experience in conducting studies with imaging and biomarker end points.
  • We are equipped to provide a full Oracle-Clinical based system suite for conventional or eCRF studies to provide full service data management, statistics, medical writing and pharmacovigilance services.
  • Quality is built into our service delivery via a stringent and globally harmonised quality management and unified SOP system, and fully validated IT infrastructure.
  • Ecron Acunova has high credibility established with European, US and Indian regulators namely FDA, EMA, BfArM, DCGI and PEI amongst others.
  • We have turned the diversity of cultures into synergistic advantages.

Therapeutic experiences:

  • Ecron Acunova has sound experience in cardiovascular diseases, dermatology, diagnostic imaging, endocrinology, ENT, gastroenterology, gynaecology, haematology, immunology, infectiology, medical devices, metabolic disorders, neurology, oncology, ophthalmology, orthopaedics, paediatrics, pulmonology, rheumatology, urology as well as unique expertise in stem cell therapy trials.

Contact details:

Europe
Hahnstrasse 70
60528 Frankfurt,
Germany
T: +49 69 668 0300
bd.europe@ecronacunova.com

India
Mobius Towers, SJR i-Park
EPIP, Whitefield
Bangalore – 560066
India
T: +91 806 691 5700
bd.asia@ecronacunova.com

United States
502 Carnegie Center
Suite 100
Princeton
NJ 08540
T: +1 973 396 2742
bd.americas@ecronacunova.com

phone +49 69 668 0300
email bd.europe@ecronacunova.com
web www.ecronacunova.com
email Hahnstrasse 70, 60528 Frankfurt
 
spacer

Member login

E-mail address:

Password:
Remember me

Industry Events

BIO-Europe Spring® 2012 — 6th International Partnering Conference

19-21 March 2012, Amsterdam RAI Convention Center, Amsterdam, The Netherlands

BIO-Europe Spring is the springtime counterpart to EBD Group’s flagship conference, BIO-Europe, and continues the tradition of providing life science companies with high caliber partnering opportunities. Featuring EBD Group’s sophisticated, web-based partnering system, partneringONE®, the event enables delegates to efficiently identify, meet and get partnerships started with companies across the life science value chain, from large biotech and pharma companies to financiers and innovative start-ups.  
More info >>

 
News and Press Releases

The Marketing Machine Helps International Pharma Client with Ambitious Literacy Drug Packaging Rebrand

Full-service advertising and branding firm The Marketing Machine recently finished an ambitious, innovative rebranding project for Danadams Pharmaceuticals Industry Limited to help overcome literacy and distribution challenges with patients in Ghana, South Africa. The firm utilized its award-winning design services team to redesign all of Danadams branding and packaging using intuitive visual icons and color elements to indicate the type of drugs and dosages and better display information more clearly and legibly. Danadams Pharmaceuticals is currently the only manufacturer of anti-retroviral drugs in West Africa. It also manufactures and sells anti-malarials, antibiotics, analgesics and other opportunistic infection drugs for the West African market.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement
.